← ClaudeAtlas

clinical-submissionlisted

Write a clinical study report on the ICH E3 skeleton — Synopsis, Ethics, Investigators/Structure, Objectives, Investigational Plan, Methods (efficacy & safety), Results, Discussion & Conclusions, Tables/Figures/Appendices — situated in the CTD five-module frame (M1-M5). Use when the deliverable must reproduce the clinical-study-report structure of a regulatory submission. Anti-trigger; for a scientific journal article write academic, for a financial/legal disclosure filing use regulatory-disclosure, not this genre — and this genre never asserts clinical validity or regulatory acceptance, only structure.
modeled-information-format/mif-docs-plugin · ★ 0 · Data & Documents · score 71
Install: claude install-skill modeled-information-format/mif-docs-plugin
# clinical-submission Produces a **clinical study report (CSR)** on the **ICH E3** skeleton, situated in the **CTD** (Common Technical Document) five-module frame. Its center of gravity is the **fixed section order** — Synopsis through Tables/Figures/ Appendices — with efficacy and safety kept distinct throughout, and every claim resolving to a cited finding. This genre follows the ICH E3 clinical-study-report convention used across regulated submissions. > **Scope caveat (carry, do not over-sell):** this genre reproduces the **ICH E3 > clinical study report structure** within the CTD module frame. It does **not** > assert clinical validity, statistical adequacy, or regulatory acceptance — the > analysis is only as sound as the cited findings. Do not market output as a > "submittable" CSR. ## Pattern (industry: ICH E3 CSR, CTD module frame) 1. **Synopsis** — a structured summary of the study and its principal results. 2. **Ethics** — ethics-committee review, informed consent, and conduct standards. 3. **Investigators & Study Structure** — administrative structure and investigators. 4. **Objectives** — the primary and secondary study objectives. 5. **Investigational Plan** — study design, randomization/blinding, and rationale. 6. **Methods (Efficacy & Safety)** — endpoints, analysis populations, and statistical methods, kept distinct for efficacy and safety. 7. **Results** — efficacy results then safety results, with the analysis populations. 8. **Discussion &